(Q37997734)

26 August 2017

Recognizing and reversing the immunosuppressive tumor microenvironment of head and neck cancer (English)

1 reference

26 August 2017

Charles C L Tong

1

1 reference

PubMed ID

22454102

26 August 2017

Johnny Kao

series ordinal

2

1 reference

PubMed ID

22454102

26 August 2017

Andrew G Sikora

series ordinal

3

1 reference

26 August 2017

1 December 2012

1 reference

26 August 2017

1 reference

26 August 2017

54

1 reference

26 August 2017

1-3

1 reference

26 August 2017

266-274

1 reference

https://scigraph.springernature.com/pub.10.1007/s12026-012-8306-6

26 August 2017

0 references

cites work

Head and neck squamous cell carcinoma: new translational therapies

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8306-6

Intratumor genomic heterogeneity correlates with histological grade of advanced oral squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8306-6

Tumor stroma and regulation of cancer development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8306-6

TP53 mutations and survival in squamous-cell carcinoma of the head and neck.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8306-6

11q13 amplification status and human papillomavirus in relation to p16 expression defines two distinct etiologies of head and neck tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8306-6

Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8306-6

Increased Prevalence of Dysplastic and Malignant Lip Lesions in Renal-Transplant Recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8306-6

Effect of reduced immunosuppression after kidney transplant failure on risk of cancer: population based retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8306-6

HPV-induced oropharyngeal cancer, immune response and response to therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8306-6

Human leukocyte antigen (HLA) class I defects in head and neck cancer: molecular mechanisms and clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8306-6

Defects in the human leukocyte antigen class I antigen processing machinery in head and neck squamous cell carcinoma: association with clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8306-6

T cell-tumor interaction directs the development of immunotherapies in head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8306-6

Co-signaling molecules of the B7-CD28 family in positive and negative regulation of T lymphocyte responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8306-6

Role of cytokines in head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8306-6

Transforming growth factor-beta in cancer and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8306-6

The multifaceted relationship between IL-10 and adaptive immunity: putting together the pieces of a puzzle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8306-6

Oral squamous cell carcinoma: histologic risk assessment, but not margin status, is strongly predictive of local disease-free and overall survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8306-6

Gr-1+CD11b+ myeloid cells tip the balance of immune protection to tumor promotion in the premetastatic lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8306-6

Microenvironmental regulation of metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8306-6

Cancer-related inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8306-6

Antigen-specific inhibition of CD8+ T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8306-6

Reduction of myeloid-derived suppressor cells and induction of M1 macrophages facilitate the rejection of established metastatic disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8306-6

The role of myeloid cells in the promotion of tumour angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8306-6

Bv8 regulates myeloid-cell-dependent tumour angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8306-6

Myeloid-derived suppressor cells promote cross-tolerance in B-cell lymphoma by expanding regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8306-6

Myeloid-derived suppressor cells as regulators of the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8306-6

Tumor-derived G-CSF facilitates neoplastic growth through a granulocytic myeloid-derived suppressor cell-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8306-6

Prognostic Value of Tumor-Infiltrating CD4+ T-Cell Subpopulations in Head and Neck Cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8306-6

Galectin-1: a link between tumor hypoxia and tumor immune privilege

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8306-6

T regulatory type 1 cells in squamous cell carcinoma of the head and neck: mechanisms of suppression and expansion in advanced disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8306-6

Expression of the T cell receptor αβ on a CD123+ BDCA2+ HLA-DR+ subpopulation in head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8306-6

Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8306-6

Therapeutic human papillomavirus vaccines: current clinical trials and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8306-6

A phase II study of Hsp-7 (SGN-00101) in women with high-grade cervical intraepithelial neoplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8306-6

Generation of T cells specific for the wild-type sequence p53(264-272) peptide in cancer patients: implications for immunoselection of epitope loss variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8306-6

Spontaneous human squamous cell carcinomas are killed by a human cytotoxic T lymphocyte clone recognizing a wild-type p53-derived peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8306-6

An MVA vaccine overcomes tolerance to human p53 in mice and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8306-6

Treatment of vulvar intraepithelial neoplasia with topical imiquimod: seven years median follow-up of a randomized clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8306-6

Treatment of vulvar intraepithelial neoplasia with topical imiquimod

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8306-6

Antiproliferative effects of cytokines on squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8306-6

Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8306-6

HIF-1α regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8306-6

Bv8 and endocrine gland-derived vascular endothelial growth factor stimulate hematopoiesis and hematopoietic cell mobilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8306-6

Reversion of immune tolerance in advanced malignancy: modulation of myeloid-derived suppressor cell development by blockade of stem-cell factor function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8306-6

Regulation of dendritic cell differentiation and antitumor immune response in cancer by pharmacologic-selective inhibition of the janus-activated kinase 2/signal transducers and activators of transcription 3 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8306-6

The novel role of tyrosine kinase inhibitor in the reversal of immune suppression and modulation of tumor microenvironment for immune-based cancer therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8306-6

Immunological effects of multikinase inhibitors for kidney cancer: a clue for integration with cellular therapies?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8306-6

Phase II study of sunitinib malate in head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8306-6

A phase II study of sunitinib in patients with recurrent and/or metastatic non-nasopharyngeal head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8306-6

Phase II study of sunitinib in recurrent or metastatic squamous cell carcinoma of the head and neck: GORTEC 2006-01.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8306-6

Phase 1 study of concurrent sunitinib and image-guided radiotherapy followed by maintenance sunitinib for patients with oligometastases: acute toxicity and preliminary response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8306-6

Arginase, prostaglandins, and myeloid-derived suppressor cells in renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8306-6

Phase I study of gefitinib plus celecoxib in recurrent or metastatic squamous cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8306-6

Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8306-6

The frequency and suppressor function of CD4+CD25highFoxp3+ T cells in the circulation of patients with squamous cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8306-6

Regulatory T cells: mechanisms of differentiation and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8306-6

Regulatory T cells and their prognostic value for patients with squamous cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8306-6

Ifosfamide in the Treatment of Head and Neck Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8306-6

Immunomodulatory effects of cyclophosphamide and implementations for vaccine design

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8306-6

Immune checkpoint proteins: a new therapeutic paradigm for cancer--preclinical background: CTLA-4 and PD-1 blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8306-6

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8306-6

Validation of genetic sequence variants as prognostic factors in early-stage head and neck squamous cell cancer survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8306-6

Association of T-cell regulatory gene polymorphisms with oral squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8306-6

Predominant expression of B7-H1 and its immunoregulatory roles in oral squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8306-6

Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8306-6

Treatment of recurrent squamous cell carcinoma of the head and neck with low doses of interleukin-2 injected perilymphatically

21 January 2018

1 reference

12 December 2020

Chemoprevention by cyclooxygenase-2 inhibition reduces immature myeloid suppressor cell expansion

1 reference

12 December 2020

Enhanced programmed death 1 (PD-1) and PD-1 ligand (PD-L1) expression in patients with actinic cheilitis and oral squamous cell carcinoma

1 reference

12 December 2020

Prognostic significance of tumor-infiltrating lymphocytes in oropharyngeal cancer

1 reference

12 December 2020

The efficacy of imiquimod on dysplastic lesions of the oral mucosa: an experimental model.

1 reference

12 December 2020

Tumor-infiltrating lymphocytes, particularly the balance between CD8(+) T cells and CCR4(+) regulatory T cells, affect the survival of patients with oral squamous cell carcinoma

1 reference

12 December 2020

Clinical significance of defective dendritic cell differentiation in cancer

1 reference

12 December 2020

Tumor associated macrophages in human prostate cancer: relation to clinicopathological variables and survival

1 reference

12 December 2020

Identification of a CD11b(+)/Gr-1(+)/CD31(+) myeloid progenitor capable of activating or suppressing CD8(+) T cells.

1 reference

12 December 2020

Cyclin D1 and p16 alterations in advanced premalignant lesions of the upper aerodigestive tract: role in response to chemoprevention and cancer development.

1 reference

12 December 2020

Neo-adjuvant chemo-(immuno-)therapy of advanced squamous-cell head and neck carcinoma: a multicenter, phase III, randomized study comparing cisplatin + 5-fluorouracil (5-FU) with cisplatin + 5-FU + recombinant interleukin 2

1 reference

12 December 2020

Observations on preprofessional education: is there a "major" difference?

1 reference

12 December 2020

Signaling abnormalities, apoptosis, and reduced proliferation of circulating and tumor-infiltrating lymphocytes in patients with oral carcinoma

1 reference

12 December 2020

Phase 1 trial of concurrent erlotinib, celecoxib, and reirradiation for recurrent head and neck cancer

1 reference

12 December 2020

Lymphocyte subpopulations infiltrating squamous carcinomas of the head and neck: correlations with extent of tumor and prognosis

1 reference

12 December 2020

Possible prognostic value of histopathologic parameters in patients with carcinoma of the oral tongue

1 reference

12 December 2020

Tumor-associated macrophage infiltration in pulmonary adenocarcinoma: association with angiogenesis and poor prognosis

1 reference

12 December 2020

Identification and functional analysis of tumor-infiltrating plasmacytoid dendritic cells in head and neck cancer

1 reference

12 December 2020

Macrophage infiltration and its prognostic implications in breast cancer: the relationship with VEGF expression and microvessel density

1 reference

12 December 2020

Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in head and neck cancers

1 reference

12 December 2020

Vaccination with HPV16 peptides of patients with advanced cervical carcinoma: clinical evaluation of a phase I-II trial

1 reference

12 December 2020

Loss of TGF-β signaling and PTEN promotes head and neck squamous cell carcinoma through cellular senescence evasion and cancer-related inflammation.

1 reference

12 December 2020

Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells

1 reference

12 December 2020

Human papillomavirus vaccines for cervical cancer

1 reference

12 December 2020

Generation of anti-p53 cytotoxic T lymphocytes from human peripheral blood using autologous dendritic cells

1 reference

12 December 2020

p53-based immunotherapy of cancer

1 reference

12 December 2020

Clinical and immunopathological results of a phase II study of perilymphatically injected recombinant interleukin-2 in locally far advanced, nonpretreated head and neck squamous cell carcinoma

1 reference

12 December 2020

Molecular and clinicopathologic comparisons of head and neck squamous carcinoma variants: common and distinctive features of biological significance

1 reference

12 December 2020

Spontaneous apoptosis of circulating T lymphocytes in patients with head and neck cancer and its clinical importance

1 reference

12 December 2020

10.1007/S12026-012-8306-6

Identifiers

DOI

1 reference

26 August 2017

1 reference

PubMed ID

22454102